Status:
COMPLETED
Gilead Sustained Virologic Response (SVR) Registry
Lead Sponsor:
Gilead Sciences
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored ...
Eligibility Criteria
Inclusion
- Key
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead oral antiviral agent (OAV)
- Have achieved SVR in a Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule and protocol-mandated procedures
- Key
Exclusion
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol
- Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Key Trial Info
Start Date :
April 13 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 8 2018
Estimated Enrollment :
6625 Patients enrolled
Trial Details
Trial ID
NCT01457755
Start Date
April 13 2012
End Date
January 8 2018
Last Update
August 31 2018
Active Locations (325)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Gastroenterology Associates
Birmingham, Alabama, United States, 35209
2
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
3
Digestive Health Specialists of the Southeast, PA
Dothan, Alabama, United States, 35305
4
Mayo Clinic
Phoenix, Arizona, United States